Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis

Medical Decision Making

Volumn 27, Issue 2, 2007, Pages 101-111

  Groot Koerkamp, Bas ^b   Hunink, M G Myriam ^a   Stijnen, Theo ^b   Hammitt, James K ^b   Kuntz, Karen M ^b   Weinstein, Milton C ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Cost effectiveness analysis; Decision making; Risk communication; Uncertainty

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; MEDICAL DECISION MAKING; NONLINEAR REGRESSION ANALYSIS; PROBABILITY; SENSITIVITY ANALYSIS; UNCERTAINTY;

COST-BENEFIT ANALYSIS; DECISION MAKING; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; MODELS, ECONOMETRIC; MORALS; POLICY MAKING; RESEARCH; UNCERTAINTY;

EID: 34147126818     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X06297394     Document Type: Article

References (42)

1. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ. 1998 ; 317: 720 - 6.
2. Multicentre Aneurysm Screening Study (MASS). cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ. 2002 ; 325: 1135.
3. United Kingdom Back Pain Exercise and Manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care. BMJ. 2004 ; 329: 1381.
4. Bower P., Byford S., Barber J., et al. Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses. BMJ. 2003 ; 326: 1247 - 50.
5. Korthals-de Bos IB, Hoving JL, van Tulder MW, et al. Cost effectiveness of physiotherapy, manual therapy, and general practitioner care for neck pain: economic evaluation alongside a randomised controlled trial. BMJ. 2003 ; 326: 911.
6. MartikainenJ., Valtonen H., Pirttila T., Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients. Eur J Health Econ. 2004 ; 5: 136 - 42.
7. Moayyedi P., Soo S., Deeks J., et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ. 2000 ; 321: 659 - 64.
8. Plant PK, Owen JL, Parrott S., Elliott MW Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial. BMJ. 2003 ; 326: 956.
9. Chilcott J., McCabe C., Tappenden P., et al. Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis. BMJ. 2003 ; 326: 522 ; discussion 522.
10. Legood R., Gray A., Wolstenholme J., Moss S. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ. 2006 ; 332: 79 - 85.
11. Iglesias C., Nixon J., Cranny G., et al. Pressure Relieving Support Surfaces (PRESSURE) trial: cost effectiveness analysis. BMJ. 2006 ; 332: 1416.
12. Rivero-Arias O., Campbell H., Gray A., Fairbank J., Frost H., Wilson-MacDonald J., Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. BMJ. 2005 ; 330: 1239.
13. Raftery JP, Yao GL, Murchie P., Campbell NC, Ritchie LD Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial. BMJ. 2005 ; 330: 707.
14. Coast J., Noble S., Noble A., et al. Economic evaluation of a general practitioner with special interests led dermatology service in primary care. BMJ. 2005 ; 331: 1444 - 9.
15. Cost effectiveness of treatment for alcohol problems: findings of the randomised UK Alcohol Treatment Trial (UKATT). BMJ. 2005 ; 331: 544.
16. Sculpher M., Manca A., Abbott J., Fountain J., Mason S., Garry R. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial. BMJ. 2004 ; 328: 134.
17. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998 ; 18 (2 suppl). S68 - 80.
18. van HoutBA, Al MJ, Gordon GS, Rutten FF Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994 ; 3 :309-19.
19. Black WC The CE-plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990 ; 10: 212 - 4.
20. Keeney RL, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Trade-offs. New York: John Wiley ; 1976.
21. Efron B., Tibshirani RJ An Introduction to the Bootstrap. New York: Chapman & Hall ; 1993.
22. Doubilet P., Begg CB, Weinstein MC, Braun P., McNeil BJ Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making. 1985 ; 5: 157 - 77.
23. BriggsAH, GoereeR., Blackhouse G., O'BrienBJ Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making. 2002 ; 22: 290 - 308.
24. Hunink Mgm, Glasziou P. Decision Making in Health and Medicine. Cambridge, UK: Cambridge University Press ; 2001.
25. Fenwick E. Claxton K. Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001 ; 10: 779 - 87.
26. Claxton K The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999 ; 18: 341 - 64.
27. Claxton K Neumann Pj Araki S Weinstein Mc. Bayesian value-of-information analysis: an application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care. 2001 ; 17: 38 - 55.
28. Devlin N., Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 2004 ; 13: 437 - 52.
29. von Winterfeldt D., Edwards W., Flat maxima in linear optimization models. Technical report number 011-313-4-T. Ann Arbor, MI: University of Michigan, Engineering Psychology Laboratory 1973.
30. Henrion M., The Value of Knowing How Little You Know: The Advantages of Probabilistic Treatment of Uncertainty in Policy Analysis. Pittsburgh: Carnegie Mellon University ; 1982.
31. Morgan MG, Henrion M Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk Policy Analysis. New York: Cambridge University Press ; 1990.
32. Ades AE, Cliffe S Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty. Med Decis Making. 2002 ; 22: 359 - 71.
33. Claxton K., Sculpher M., Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet. 2002 ;360: 711 - 5.
34. Raiffa H. Decision Analysis: Introductory Lectures on Choices under Uncertainty. Reading, MA: Addison-Wesley; 1968.
35. Felli JC Hazen GB Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998 ; 18: 95 - 109.
36. Ades AE, Lu G., Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004 ; 24: 207 - 27.
37. Yokota F., ThompsonKM Value of information literature analysis: a review of applications in health risk management. Med Decis Making. 2004 ; 24: 287 - 98.
38. Groot Koerkamp B, Myriam Hunink MG, Stijnen T, Weinstein MC. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods. Health Econ. 2006 ; 15: 383 - 92.
39. Gardner MJ, Altman DG Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed). 1986 ; 292: 746 - 50.
40. Poole C Beyond the confidence interval. AJPH. 1987 ; 77: 195 - 9.
41. Heitjan Df, Moskowitz Aj, Whang W. Problems with interval estimates of the incremental cost-effectiveness ratio. Med Decis Making. 1999 ; 19: 9 - 15.
42. Kent Dm, Fendrick Am, Langa Km. New and dis-improved: on the evaluation and use of less effective, less expensive medical interventions. Med Decis Making. 2004 ; 24: 281 - 6.